Association between malnutrition risk and the prognosis of geriatric heart failure patients undergoing left ventricular assist device implantation - 16/10/24

Doi : 10.1016/j.jnha.2024.100382 
Rui Shi a, 1, Zhenhan Li b, 1, Xinyue Duan c, Jun Luo d, Yuxiang Luo d, Qingchen Wu d, Dan Chen d, Xin Tian e, Hongtao Tie d,
a Department of Critical Care Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China 
b Department of Endocrinology, Chongqing Traditional Chinese Medicine Hospital, Chongqing, China 
c The First College of Clinical Medicine, Chongqing Medical University, Chongqing, China 
d Department of Cardiothoracic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China 
e Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing, China 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Background

Evidence regarding the association between malnutrition risk and the prognosis of geriatric heart failure (HF) patients undergoing left ventricular assist device (LVAD) implantation is lacking. Our study aims to investigate how malnutrition risk, assessed using the geriatric nutritional risk index (GNRI) values, relates to the outcomes of geriatric HF patients undergoing LVAD, using data from the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) registry.

Methods

A retrospective analysis was conducted using data from INTERMACS registry. Patients aged 65 and above who received LVAD implantation between 2008 and 2017 were included. The GNRI was used to stratify patients into three groups: absence of risk (GNRI > 98), mild risk (GNRI 92–98), and moderate to severe risk (GNRI < 92). The primary outcome was long-term survival for up to four years following LVAD implantation.

Results

We included 5429 patients aged 65 and above undergoing LVADs. The malnutrition risk was presented in 75.8% of the patients before implantation, decreasing to 32.4% at 3 months, and 59.5% at 24 months post-implantation. Moderate-to-severe malnutrition risk, both pre-implant and 6 months post-implant, was associated with an increased risk of death (pre-implant: hazard ratio (HR): 1.25 [95% CI: 1.12–1.40], p < 0.001; 6 months: HR: 2.36 [95% CI: 2.01–2.77], p < 0.001). Mortality decreased with increasing pre-implant GNRI up to approximately 100 and 6-month post-implant GNRI up to 104. Patients with malnutrition risk also had an increased risk of infection, poor quality of life (QoL), and reduced functional exercise capacity after the LVAD implantation.

Conclusions

Malnutrition risk was highly prevalent in HF patients aged 65 and above undergoing LVADs implantation. The presence of malnutrition risk was associated with an increased risk of death, infection, poor quality of life, and reduced functional exercise capacity.

El texto completo de este artículo está disponible en PDF.

Abbreviations : CCI, CIFs, ECMO, HF, HR, IABP, IBW, INTERMACS, GNRI, KCCQ, LVAD, QoL, RCS, SHR, 6MWT

Keywords : Heart failure, LVAD, Nutrition status, GNRI


Esquema


© 2024  The Authors. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 28 - N° 12

Artículo 100382- décembre 2024 Regresar al número
Artículo precedente Artículo precedente
  • Tackling aging muscle loss throughout lesser mealworm protein supplementation
  • Bruno Remigio Cavalcante, Mariana Ferreira de Souza
| Artículo siguiente Artículo siguiente
  • Associations of three healthy dietary patterns with homeostatic dysregulation: results from the China Multi-Ethnic Cohort study
  • Hongmei Zhang, Quzong Deji, Ning Zhang, Yi Xiang, Yuan Zhang, Jiajie Cai, Tingting Yang, Jianzhong Yin, Yonglan Wei, Xianbin Ding, Xiong Xiao, Xing Zhao

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.